• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

Burden of Hidradenitis Suppurativa on Patients and Diagnostic Challenges

Author(s):

Merrick D. Elias, DO, FAAD,Hadar Avihai Lev-Tov, MD

Panelists discuss how hidradenitis suppurativa significantly impacts patients' quality of life through chronic pain, skin lesions, and social stigma, while remaining frequently misdiagnosed or diagnosed late due to low disease awareness among healthcare providers.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Related Videos
      Utility of Molecular Testing in Skin Cancer Risk Assessment
      Utility of Molecular Testing in Skin Cancer Risk Assessment
      Limitations and Challenges in Skin Cancer Staging Systems
      Limitations and Challenges in Skin Cancer Staging Systems
      4 experts are featured in this series.
      Talking to Patients About the Safety of JAK Inhibitors in Atopic Dermatitis
      2 experts in this video
      Mechanism of Action Differences Among IL-17 Inhibitors
      2 experts in this video
      The Role of IL-17 in Psoriasis Pathogenesis
      4 experts are featured in this series.
      Navigating the Boxed Warning for the JAK Inhibitor Class
      1 expert in this video
      Personalized Photoprotection Based on Patient Factors
      1 expert in this video
      Impact of Oxidative Stress on Skin Health and the Utility of Antioxidants
      1 expert in this video
      Laboratory Monitoring for JAK Inhibitors and Key Takeaways
      1 expert in this video
      Options for Eyebrow and Eyelash Regrowth in a 32-Year-Old Female With Alopecia Areata
      Related Content
      Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 2
      March 21st 2025

      Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 2

      The Cutaneous Connection: Episode 1- Cannabinoid Use in Dermatology
      June 25th 2020

      The Cutaneous Connection: Episode 1- Cannabinoid Use in Dermatology

      Povorcitinib Demonstrates Promising Phase 3 Results for Hidradenitis Suppurativa Treatment
      March 17th 2025

      Povorcitinib Demonstrates Promising Phase 3 Results for Hidradenitis Suppurativa Treatment

      Amlitelimab Demonstrates Durable Response in Atopic Dermatitis
      March 14th 2025

      Amlitelimab Demonstrates Durable Response in Atopic Dermatitis

      Key Insights from Novartis at AAD and AAAAI: Flexibility and Personalization in Dermatology Treatment
      March 14th 2025

      Key Insights from Novartis at AAD and AAAAI: Flexibility and Personalization in Dermatology Treatment

      InflaRX Presents Efficacy and Safety Data on Vilobelimab at AAD 2025
      March 11th 2025

      InflaRX Presents Efficacy and Safety Data on Vilobelimab at AAD 2025

      © 2025 MJH Life Sciences

      All rights reserved.